VACCINEX, INC. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Vaccinex, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2017 to 2023.
  • Vaccinex, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $6.07M, a 200% increase year-over-year.
  • Vaccinex, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $12.4M, a 26.7% decline from 2022.
  • Vaccinex, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $17M, a 27.2% decline from 2021.
  • Vaccinex, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $23.3M, a 36.5% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $12.4M -$4.53M -26.7% Jan 1, 2023 Dec 31, 2023 10-K/A 2024-04-25
2022 $17M -$6.35M -27.2% Jan 1, 2022 Dec 31, 2022 10-K/A 2024-04-25
2021 $23.3M -$13.4M -36.5% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 $36.8M +$23M +166% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2019 $13.8M -$27.2M -66.3% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-31
2018 $41M +$17M +70.8% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-09
2017 $24M Jan 1, 2017 Dec 31, 2017 10-K 2019-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.